Add to MyYahoo RSS

Express Scripts News

News on Express Scripts (Ticker: ESRX) continually updated from thousands of sources around the net.

20 hrs ago | Investopedia

Drugstore Wars: Walgreen Vs. CVS

I hope I'm not dating myself too much, but I remember when the neighborhood chain drugstore was almost a one-stop shop for human needs.


Related Topix: Retail, CVS, Walgreens, Social Solutions

Tue Apr 15, 2014

Belleville News Democrat

Daily business briefing: St. Louis execs among nation's highest paid

Some St. Louis executives have landed on the Equilar 100 CEO Pay Study. The median pay for the 100 CEOs on the list was $13.9 million, up 9 percent from last year.


Related Topix: Boeing, Social Solutions, Beverages, Coca-Cola Bottling Co.

Business Journal

New health exchange enrollees are using lots of specialty drugs, but few contraceptives

Express Scripts analyzed pharmacy benefit claims from 400,000 exchange members covered by the company from Jan. 1 to Feb. 28. Early data released by the nation's largest pharmacy benefits manager provides a snapshot of the health of the individuals who have so far enrolled in the health insurance exchanges that are part of the Affordable Care Act.


Related Topix: Social Solutions

Mon Apr 14, 2014

Bristol-Myers submits NDA for Reyataz-cobicistat combo for HIV-1

Attack on Gilead Sovaldi by Express Scripts 'noise,' says Maxim After Bloomberg reported that Express Scripts said that it would attempt to build a coalition against the use of Gilead's Sovaldi once a rival drug is approved, Maxim views Express Scripts' statement as "noise."


Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Bristol Myers Squibb, Food and Drug Administration, Hepatitis, Health

Sat Apr 12, 2014


Cost of highly effective hepatitis drug spurs revolt

And at $1,000 a daily pill, or $84,000 over 12 weeks of treatment, the medication could generate as much as $19 billion nationwide in revenue in the next three years for maker Gilead Sciences in Foster City.


Related Topix: Hepatitis, Medicine, Health, Biotech, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, Social Solutions

Fri Apr 11, 2014

Investment Analysts' Ratings Reiterations for April, 11th (ASOMF,...

They currently have a $52.00 target price on the stock. Zacks' analyst wrote, "We have maintained our Neutral recommendation on Avery Dennison with a target price of $52.00.


Related Topix: Office Equipment, Avery Dennison

Thu Apr 10, 2014

Business Insurance

Spike in use of compounded medications leads workers comp cost increases

The utilization and cost of compounded medications in workers compensation claims spiked last year, while the costs of antidepressants and non-narcotic painkillers also continued to rise, according to a report released Thursday by pharmacy benefit manager Express Scripts Inc. The use of compounded medications, which include oral and topical ... (more)


Related Topix: Social Solutions, Medicine, Arthritis, Health, Pain, Food and Drug Administration

ISI Group Lowers Express Scripts Holding Company Price Target to $75.00

ISI Group's price target suggests a potential upside of 1.05% from the stock's previous close.


Wed Apr 09, 2014

Greenwich Citizen

Report: Exchanges yield more specialty drug claims

Patients from the health care overhaul's new insurance exchanges have been more likely to use expensive specialty drugs for chronic conditions, according to data from the nation's largest pharmacy benefits manager.



Gilead Sciences: Pricing Concerns Just Noise?

Maxim Group's Jason Kolbert thinks the controversy over the cost of Gilead Sciences' Sovaldi is overblown.


Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry


Pharmacy Benefit Manager Express Scripts Inc. Enraged, Looks To Force ...

Express Scripts plans to ask its clients, which include employers, health insurance plans and government agencies, to join a group that would stop using Gilead's Sovaldi treatment for Hepatitis C once the FDA has approved rival drugs.


Related Topix: Medicine, Hepatitis, Health

Tue Apr 08, 2014

The Washington Post

Express Scripts Raises Pressure on Gilead to Cut Drug Price

Express Scripts Holding Co., a pharmacy benefit manager that handles more than 1 billion prescriptions a year in the U.S., is ratcheting up its effort to force Gilead Sciences Inc. to cut the $84,000 price of its new hepatitis C pill Sovaldi.


Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Social Solutions, Hepatitis, Health, Health Insurance, Business News

Mon Apr 07, 2014

KSDK-TV Saint Louis

St. Louis Career Fair this weekSt. Louis Career Fair this weekExpress ...

Express Scripts and Job News are sponsoring the St. Louis Career Fair this week at the Doubletree Hotel in Westport Plaza.


Related Topix: Social Solutions

Applied Clinical Trials

United BioSource Corp. Named Preferred Oncology Clinical Research...

United BioSource Corp. , a subsidiary of Express Scripts ESRX , has been named the preferred oncology clinical research partner by RT Oncology Services Corp. , the nation's leading community oncology alliance.


The Motley Fool

Can Express Scripts Holding Co. Beat Expectations Again?

Analysts are skeptical that, with the large advances already made in the shift to generics, Express Scripts can leverage formulary design, producer discounts, mail delivery and other drivers to continue generating double-digit free cash flow growth.


Related Topix: Beverages, United Group

Thu Apr 03, 2014

Commentary: Immigrants Will Help Rebuild St. Louis

St. Louis has long benefited from immigrants. At the turn of the 20th century, St. Louis had almost 600,000 inhabitants, making it the fourth largest city in the nation behind New York, Chicago and Philadelphia.


Related Topix: SAFECO, Monsanto, Sigma-Aldrich, Insurance, Chemicals, SigmaAldrich


Thursday's ETF with Unusual Volume: IHF

The iShares U.S. Healthcare Providers ETF is seeing unusually high volume in afternoon trading Thursday, with over 245,000 shares traded versus three month average volume of about 28,000.


Related Topix: Beverages, United Group, Social Solutions, Business News, Video

Tue Apr 01, 2014

Express Scripts Holding Company PT Raised to $86.00

Jefferies Group's price target would indicate a potential upside of 13.04% from the company's current price.


Thu Mar 27, 2014

Business Journal

Express Scripts' George Paz sees jump in pay

Express Scripts Chairman and CEO George Paz's total compensation in 2013 was $13.04 million, an increase from his $12.75 million total compensation in 2012, according to the company's proxy statement.


Tue Mar 25, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The report is available at ''. Additional information is available at ' )--Contact Law Offices of Howard G. Smith if you purchased the securities of InnerWorkings, Inc. between February 15, 2012 and November 6, 2013.


Related Topix: US Governors, Mike Pence, QD Vision, Food, Flowers Foods, Agriculture, Virginia Beach, VA, Real Estate, Glimcher Realty Trust


Ashburn Jobs